We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CRESY market cap is 0. The company's latest EPS is ARS and P/E is N/A.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Total Revenue | 39.16B | 41.76B | 94.5B | 170.61B | 58.23B |
| Operating Income | 6.83B | 5.62B | -40.75B | 114.35B | -31.18B |
| Net Income | 5.34B | 9.91B | 21.74B | 40.78B | 8.02B |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Total Revenue | 98.64B | 166.99B | 100.54B | 121.83B | 206.88B |
| Operating Income | 8.91B | 42.88B | 3.89B | 26.45B | -22.39B |
| Net Income | -18.75B | 3.93B | -12.57B | 37.09B | 42.22B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Total Assets | 713.6B | 847.71B | 1.07T | 1.56T | 2.69T |
| Total Liabilities | 416.51B | 472.04B | 589.22B | 835.39B | 1.55T |
| Total Equity | 297.09B | 375.67B | 480.13B | 721.15B | 1.14T |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Total Assets | 507.99B | 686.94B | 339.17B | 529.23B | 1.07T |
| Total Liabilities | 418.99B | 564.79B | 233.28B | 322.44B | 589.22B |
| Total Equity | 89B | 122.15B | 105.89B | 206.79B | 480.13B |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Operating | -371M | 6.48B | 35.97B | 35.68B | 48.77B |
| Investing | 5.5B | 41.31B | 14.92B | 3.06B | 54.29B |
| Financing | -33.05B | -53.86B | -90.74B | -24.97B | -112.5B |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | ARS (ARS) | |
| Operating | 17.87B | 35.73B | 8.89B | 21.81B | 35.97B |
| Investing | 7.38B | 40.31B | 73.66B | 12.89B | 14.92B |
| Financing | -18.01B | -72.62B | -54.17B | -37.02B | -90.74B |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 0 |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.2 (20.56%) |
| Company Name | Cresud S A C I F y A |
| Address |
carlos della paolera 261 piso 9 buenos aires, federalization of buenos aires |
| Website | https://www.cresud.com.ar |
| Industry | gen farms-lvstk, animal spec (0291) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
